Biotech

All Articles

ArsenalBio increases $325M, pivots out of past lead asset

.Toolbox Biosciences is actually carrying on up. The cell therapy provider has actually added $325 t...

Lilly- backed weight-loss biotech data IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually sub...

Aelis' marijuana usage medicine fails stage 2b, driving Indivior to reassess $100M alternative

.Aelis Farma's chances of safeguarding a quick, positive choice on a $100 thousand alternative settl...

ProKidney halts phase 3 test certainly not needed to have for cell therapy approval

.ProKidney has stopped some of a set of stage 3 trials for its own tissue therapy for renal conditio...

Vaxcyte climbs on 'spectacular' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what experts called "impressive" period 1/2 records for its own 31-valent pneumoco...

Recursion's human brain condition test shows scant documentation of efficiency

.Recursion has actually discovered through an early examination of its tech-enabled method to medici...

Acepodia, Pfizer click all together for chemistry-based tissue treatment

.Call it an instance of really good chemical make up: Acepodia, a biotech based on Nobel Prize-winni...

Praxis epilepsy drug minimizes confiscations in stage 2 hearing

.Practice Accuracy Medicines has scored another midphase succeed in epilepsy this year, along with i...

Three execs resign as Dyne blog posts mixed information for DMD applicant

.After running away a medical grip many years back, Dyne Therapeutics has actually revealed new peri...

Arrowhead fires off stage 3 information in unusual metabolic health condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has revealed its own give in front of a possible face-off with Ionis, pub...